Marleen Kok
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Marleen Kok
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 13, 2024, 20:21 |
Blog
Antoni van Leeuwenhoek has been awarded with grant of 4.1 million eur
Marleen Kok shared Antoni van Leeuwenhoek's post on LinkedIn, adding: "Incredibly proud of my team…
Jul 10, 2024, 05:38 |
Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
May 24, 2024, 09:55 |
Blog
Eva Schumacher-Wulf: My personal highlights from ESMOBreast24
Eva Schumacher-Wulf, Editor-in-Chief of Mamma Mia! Magazine, shared on LinkedIn: "Before I head to Chicago…
May 18, 2024, 08:31 |
Opinion
Guillermo Villacampa: Marleen Kok presents the ESMO Breast 24 key message in translation research
Paolo Tarantino shared the following post by Guillermo Villacampa, Biostatistician in the Oncology Data Science…
May 17, 2024, 11:25 |
Insight
Stefan Michiels: Discussing important clinical trial design challenges in breast cancer!
Stefan Michiels, Head Oncostat Team at INSERM, shared a post by Marleen Kok, Associate Professor…
Apr 29, 2024, 22:33 |
Blog
Marleen Kok: Institutional visit by Ulrike Harjes, Senior Editor of Nature Medicine, to The Netherlands Cancer Institute
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X/Twitter: ''Institutional…
Jan 22, 2024, 17:43 |
Blog
Marleen Kok: Such a joy to see you shine
Marleen Kok, Associate Professor at The Netherlands Cancer Institute shared a post by Olga Blomberg,…
Dec 6, 2023, 11:43 |
Insight
Vivek Subbiah: Excited and honored to attend the San Antonio Breast Conference meeting
Vivek Subbiah shared on LinkedIn: "Excited and honored to attend the San Antonio Breast Conference…
All:
9
Posts:
1 - 100
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Facebook
RSS Feed
Twitter
Linkedin
Youtube